Statera Biopharma Inc (STAB)

Statera Biopharma Inc (STAB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7,141; returns 1 day -50.0%.

Statera Biopharma Inc. (formerly Cytocom) is a clinical-stage biopharmaceutical company focused on developing immunotherapies that target the immune system's toll-like receptors (TLRs) to restore homeostasis. The company's business model has shifted from direct drug development to a licensing and strategic partnership framework.

Groups STAB belongs to

• Biopharmaceutical
• Clinical Stage Biopharma
• Clinical Stage
• Immunotherapy
• Biotechnology
• Healthcare
• Life Sciences
• Drug Discovery
• Oncology
• Autoimmune Diseases

STAB financial model: income statement, cash flow and balance sheet